Adrenal glucocorticoids exert powerful effects on cellular excitability in neuroendocrine cells and neurons, although the underlying mechanisms are poorly understood. In metabolically intact mouse anterior pituitary corticotrope (AtT20) cells glucocorticoid-induced proteins render large conductance calcium-activated potassium (BK) channels insensitive to inhibition by protein kinase A (PKA). In this study we have addressed whether this action of glucocorticoids is mediated via protein phosphatase activity at the level of single BK channels. In isolated inside-out patches from control AtT20 cells BK channels (125 pS) were inhibited by activation of closely associated PKA. Pretreatment (2 h) of cells with 1 M dexamethasone before patch excision did not modify the intrinsic properties or expression levels of BK channel ␣-subunits in AtT20 cells. However, PKAmediated inhibition of BK channel activity in isolated patches from steroid-treated cells was severely blunted. This effect of steroid was not observed using adenosine 5-O-(3-thiotriphosphate) as phosphate donor or on exposure of the intracellular face of the patch with 10 nM of the protein phosphatase inhibitors okadaic acid or calyculin A but was mimicked by application of protein phosphatase 2A (PP2A) to the intracellular face of patches from control cells. Glucocorticoids did not modify total PP2A activity in AtT20 cells, suggesting that modified PP2A-like phosphatase activity closely associated with BK channels is required for glucocorticoid action.
Adrenal glucocorticoids exert powerful effects on cellular excitability in neuroendocrine cells and neurons, although the underlying mechanisms are poorly understood. In metabolically intact mouse anterior pituitary corticotrope (AtT20) cells glucocorticoid-induced proteins render large conductance calcium-activated potassium (BK) channels insensitive to inhibition by protein kinase A (PKA). In this study we have addressed whether this action of glucocorticoids is mediated via protein phosphatase activity at the level of single BK channels. In isolated inside-out patches from control AtT20 cells BK channels (125 pS) were inhibited by activation of closely associated PKA. Pretreatment (2 h) of cells with 1 M dexamethasone before patch excision did not modify the intrinsic properties or expression levels of BK channel ␣-subunits in AtT20 cells. However, PKAmediated inhibition of BK channel activity in isolated patches from steroid-treated cells was severely blunted. This effect of steroid was not observed using adenosine 5-O-(3-thiotriphosphate) as phosphate donor or on exposure of the intracellular face of the patch with 10 nM of the protein phosphatase inhibitors okadaic acid or calyculin A but was mimicked by application of protein phosphatase 2A (PP2A) to the intracellular face of patches from control cells. Glucocorticoids did not modify total PP2A activity in AtT20 cells, suggesting that modified PP2A-like phosphatase activity closely associated with BK channels is required for glucocorticoid action.
Glucocorticoid hormones exert profound effects on cellular excitability in endocrine and nerve cells through regulation of ion channel activity that requires the rapid induction of new proteins (1) (2) (3) . Increasing evidence suggests that potassium channels are major targets for glucocorticoid action. Although glucocorticoids rapidly induce potassium channel subunits in some systems (4, 5) , the mechanisms of channel regulation by glucocorticoids in endocrine cells and neurons are largely not understood (1) (2) (3) .
Anterior pituitary corticotrope cells have been widely used as a physiologically relevant model system to explore the mechanisms of early glucocorticoid action (6, 7) . In the mouse corticotrope cell line, AtT20 D16:16, the cAMP-mobilizing neuropeptide, corticotrophinreleasing factor, stimulates adrenocorticotropin secretion through the concerted action of protein kinase A (PKA) 1 to activate L-type calcium channels and inhibit BK channels and subsequent enhancement of calcium influx through L-type calcium channels (3, 8) . In turn, glucocorticoids rapidly (within 2 h) inhibit corticotropinreleasing factor-stimulated secretion through the induction of new proteins (9, 10) . We have previously demonstrated in metabolically intact AtT20 D16:16 corticotropes that glucocorticoid-induced proteins render BK channels insensitive to inhibition by protein kinase A and that the action of the steroid is central for the early inhibition of adrenocorticotropin hormone secretion in this system (3). Intriguingly glucocorticoids also block protein kinase A-mediated inhibition of calcium-activated potassium channels underlying the slow after-hyperpolarization in hippocampal neurons (1, 11) , suggesting that calcium-activated potassium channels are common targets for reciprocal regulation of cellular excitability by glucocorticoid-induced proteins and cAMP-dependent phosphorylation.
In corticotropes, glucocorticoid-induced proteins may modulate other signaling pathways to regulate BK channel activity or may directly modulate BK channel function themselves. Increasing evidence suggests that the activity of BK channels are dynamically regulated by the interaction of protein kinases and phosphatases intimately associated with the channel complex (12) (13) (14) (15) . Because glucocorticoids specifically antagonize PKA-mediated regulation of BK channels but not L-type calcium channels in AtT20 D16:16 cells (3), we hypothesized that glucocorticoids may exert their effects through protein phosphatase activity at the level of the BK channel complex itself. Indeed increasing evidence from other systems suggests that glucocorticoids mediate some of their effects through regulation of serine/threonine as well as tyrosine-protein phosphatase activity (16 -19) .
Inhibition of protein phosphatases modulates cAMP accumulation and metabolism in intact AtT20 D16:16 cells (20) and glucocorticoid receptor function in many cell types (21) thus precluding definitive analysis of the mechanism of glucocorticoid action at the level of BK channels themselves in intact cells. Thus to directly address whether protein phosphatases are involved in the ability of glucocorticoids to block PKAmediated inhibition of BK channel activity we have examined the regulation of BK channel activity in excised inside-out patches from control and glucocorticoid-pretreated AtT20 D16:16 corticotropes. The data in this report demonstrate that glucocorticoid regulation of BK channel activity requires protein phosphatase 2A activity closely associated with the BK channel complex.
EXPERIMENTAL PROCEDURES
AtT20 D16:16 Cell Culture-Clonal mouse anterior pituitary (AtT20 D16:16, passage 18 -32) cells were maintained as described previously (3) and used 3-7 days post-plating on glass coverslips. Cells were treated with 1 M of the synthetic glucocorticoid dexamethasone or vehicle (Ͻ0.01% Me 2 SO) for 2 h at 37°C in serum-free Dulbecco's modified Eagle's medium, pH 7.4, buffered with 25 mM HEPES and containing 0.25% bovine serum albumin. Cells were then transferred to the bath solution (dexamethasone-free) outlined below for electrophysiological recording. Regulation of single channel events in isolated inside-out patches from control or dexamethasone-treated cells was performed in parallel on the same passage of cells to avoid potential intra-passage variations in responsiveness.
Electrophysiology-Single BK channel events were recorded in the inside-out patch configuration of the patch clamp technique using physiological potassium gradients. The bath (intracellular face of patch) solution contained in ( BK channel modulators were applied in bath solution to the intracellular face of the patch using 10 volumes of the recording bath solution (bath volume, 0.5 ml) by gravity driven perfusion at a flow rate of 1-2 ml/min. For experiments with purified PP2A catalytic subunits, agents were added directly to the bath. In preliminary experiments, application of purified catalytic subunits of PKA to the intracellular face of the patch resulted in highly variable inhibitory effects on BK channel activity in this system. As such, the highly reproducible effect of cAMP was used to monitor PKA-mediated BK channel activity in subsequent experiments (see "Results"). In experiments examining regulation of single BK channel mean open channel probability (Po), change in Po (expressed as a percentage of pretreatment Po) was determined from the Po calculated before and 10 min after the application of the respective agent(s) to the intracellular face of the patch (see "Results" and "Discussion").
Western Blotting-Crude membrane homogenates from AtT20 D16:16 cells were prepared by homogenizing ϳ10 7 cells on ice in homogenization buffer (in mM): 50 Tris-HCl, pH 7.4, 140 KCl, 1 EGTA, 1 MgCl 2 containing 12 units/ml aprotinin, 5 g/ml leupeptin, 6 mM 4-(2-aminoethyl)benzenesulfonylfluoride, and 4 mM pepstatin A followed by two freeze thaw cycles. After centrifugation for 5 min 1000 ϫ g at 4°C the resultant supernatant was pelleted at 20,000 ϫ g to give the crude membrane fraction. Protein samples (15 g) were separated on a 10% SDS gel and electroblotted to Immobilon polyvinylidene difluoride membranes. Membranes were blocked for 2 h at room temperature with PBS containing 0.1 mM EDTA, 0.1% Triton X-100, pH 7.4, (PBS-TE) and 5% (w/v) low fat milk (Marvel). Blots were incubated overnight at 4°C with a 1:2000 dilution of the affinity purified antibody ␣slo (913-926) (directed toward residues 913-926 of the pore-forming ␣-subunit of mouse brain BK channels; Ref. 22) in PBS-TE containing 1% (w/v) Marvel. Blots were washed five times with PBS-TE and incubated for 45 min at room temperature with horseradish peroxidase-labeled antirabbit IgG (Amersham Pharmacia Biotech, 1:5000 final dilution) in PBS-TE containing 5% (w/v) Marvel. After five washes in PBS-TE, blots were incubated with Amersham Pharmacia Biotech ECL reagents according to the manufacturer's protocol, and blots were exposed to ECL film in the linear response range (Amersham Pharmacia Biotech).
Protein Phosphatase Assays-Protein phosphatase activity of crude cytosolic and membrane fractions were determined by using the molybdate:malachite green:phosphate complex assay using the synthetic phosphopeptide RRA(pT)VA as substrate essentially as described by the manufacturer (Promega Corporation, Madison, WI). Cytosolic and crude membrane fractions were prepared from control and dexamethasone-treated AtT20 D16:16 cells as for Western blotting in homogenization buffer (in mM): 50 Tris-HCl, pH 7.4, 140 KCl, 1 EGTA, 1 MgCl 2 containing 12 units/ml aprotinin, 5 g/ml leupeptin, 6 mM 4-(2-aminoethyl)benzensulfonylfluoride, and 4 mM pepstatin A. To remove endogenous phosphate, cytosolic fractions were passed twice through a 10-ml bed volume of Sephadex G-25, resuspended membrane fractions were incubated for 20 min at 4°C with 10 volumes of Sephadex G-25, and the 200 ϫ g supernatant was washed and pelleted twice at 20,000 ϫ g in Tris-HCl as above. Phosphatase assays were performed in a volume of 50 l in imidazole buffer (in mM: 50 imidazole, pH 7.2, containing 0.2 EGTA, 0.02% (v/v) ␤-mercaptoethanol, and 0.1 mg/ml bovine serum albumin) for 30 min at 30°C using 100 M of RRA(pT)VA as substrate. PP2A activity was determined as the difference in total phosphatase activity and phosphatase activity in the presence of 10 nM okadaic acid. Under the conditions used Ͼ80% of phosphatase activity was sensitive to 10 nM okadaic acid. Reaction was terminated by addition of the molybdate dye buffer and incubated for 30 min at room temperature, and absorbance was determined at 600 nm.
Reagents-Purified protein phosphatase 2A catalytic subunit and reagents for PP2A activity assay were from Promega Corporation (Southampton, UK). Calyculin A, okadaic acid, and norokadone were from LC Laboratories (Alexis Corporation Ltd., Nottingham, UK). The specific protein kinase A inhibitor peptide (PKI (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) ) was from Sigma or Calbiochem-Novabiochem Ltd. (Nottingham, UK). Tetrodotoxin was from Calbiochem-Novabiochem Ltd. (Nottingham, UK). Polyvinylidene difluoride membranes and reagents for SDS-polyacrylamide gel electrophoresis and Western blotting were from Bio-Rad Laboratories, Ltd. (Hertfordshire, UK). All other reagents were from Sigma or BDH-Merck (Poole, Dorset, UK). Dexamethasone was stored at Ϫ20°C at 10 mM in Me 2 S0.
Statistics-Data are expressed as the means Ϯ S.E. Statistical significance was determined by Student's t test for paired and unpaired data as appropriate. A p value of less than 0.05 was considered to be significant.
RESULTS
In inside-out patches from control AtT20 D16:16 corticotropes single BK channel events were characterized by their slope conductance (125 Ϯ 3 pS in physiological potassium gradients and 2 mM intracellular magnesium, reduced to 80 Ϯ 4 pS with 10 mM internal magnesium) and sensitivity to voltage and calcium ( Fig.  1 A-C) . Over the physiological voltage range of AtT20 D16:16 cells, more than 75% (not shown) of single BK channels are half-maximally activated at positive (20 -30 mV) potentials at "resting" 0.1 M intracellular free calcium [Ca 2ϩ ] i levels (Fig. 1B) . At levels of intracellular free calcium observed during secretagogue stimulation (1 M) BK channels are maximally activated (Fig. 1B , half-maximal activation Ͻ Ϫ40 mV, not shown).
Dexamethasone Does Not Modify Single Channel BK Channel Properties or Expression Levels-Pretreatment of AtT20 D16:16 cells with a maximally effective concentration (1 M) of the synthetic glucocorticoid agonist, dexamethasone (3, 10) , had no significant effect on single channel slope conductance (125 Ϯ 2 and 80 Ϯ 3 pS with 2 and 10 mM internal magnesium, respectively, Fig. 1A ) or sensitivity to voltage or calcium in inside-out patches (Fig. 1, A-C) . Half-maximal activation of BK channels in 0.1 M [Ca 2ϩ ] i in greater than 70% of patches was observed between 20 -30 mV (Fig. 1B) .
Immunoblotting of crude plasma membrane fractions from control and dexamethasone-treated AtT20 D16:16 corticotropes using an affinity purified antibody (␣slo (913) (914) (915) (916) (917) (918) (919) (920) (921) (922) (923) (924) (925) (926) ) directed toward residues 913-926 (22) of the ␣-subunit (pore-forming subunit) of BK channels revealed a single immunoreactive band at approximately 125 kDa (Fig. 2 ). No significant difference in level of expression was observed between control and dexamethasone-treated AtT20 D16:16 corticotropes ( 3 , A-C) that was maximal within 10 min and was maintained for more than 30 min. On washout of cAMP mean channel open probability gradually returned toward pretreatment levels; this reversal was accelerated by removal of ATP from the intracellular face of the channel (not shown). The inhibitory action of cAMP was mediated through protein kinase A-like activity closely associated with the channel in the patch because no significant inhibition of Po was observed on application of cAMP in the presence of the specific protein kinase A inhibitor peptide, PKI (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (percentage of change in Po, 0.9 Ϯ 5.3%; n ϭ 4) or in the absence of ATP (percentage of change in Po, 7.0 Ϯ 10.1%; n ϭ 4) (Fig. 3C) .
Pretreatment of Cells with Dexamethasone Attenuates PKAmediated Inhibition of BK Channels in Isolated Inside-Out
Patches-In parallel experiments, application of cAMP to the intracellular face of inside-out patches from dexamethasonetreated cells resulted in a significantly attenuated inhibition of mean channel open probability compared with inhibition observed in patches from control cells (Fig. 3, B and C) . In patches from dexamethasone-treated cells the percentage of change in Po was Ϫ22.4 Ϯ 7.1%, n ϭ 9 (compared with Ϫ72.9 Ϯ 9.5%, n ϭ 8, in control patches, p Ͻ 0.01 t test, Fig. 3C ). The blockade of PKA-mediated inhibition was not a result of delayed responsiveness to cAMP (Fig. 3B) ; in addition the effect of cAMP was mediated through activation of endogenous PKA (Fig. 4B ).
An Okadaic Acid-sensitive Phosphatase, Closely Associated with BK Channels, Is Required for Dexamethasone Action-The thiophosphate of ATP␥S can be used by protein kinases to phosphorylate target proteins, but the resultant phosphoprotein is largely resistant to dephosphorylation. Using ATP␥S as the phosphate donor in place of ATP in patches from dexamethasone-treated cells, cAMP inhibited Po to the same extent as that observed in control cells (percentage of change in Po, Ϫ60.8 Ϯ 12.3%, Fig. 3C ). These data suggest that a closely associated protein phosphatase is responsible for the attenuation of PKA-mediated inhibition of single BK channels in isolated patches from dexamethasone-treated cells.
In support of this, application of 10 nM okadaic acid or 10 nM calyculin A to the intracellular face of isolated patches from dexamethasone-treated cells resulted in cAMP-mediated inhibition of BK channel Po to the same extent as that seen in control patches with cAMP alone or in conjunction with the phosphatase inhibitors (Figs. 3C and 4B ). For okadaic acid cAMP-mediated inhibition in patches from control cells expressed as the percentage of change in pretreatment Po was Ϫ69.8 Ϯ 6.9% (n ϭ 6) for dexamethasone cells Ϫ70.2 Ϯ 13.2% (n ϭ 6). The effect of cAMP in the presence of okadaic acid was completely blocked by PKI (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) in patches from both control (percentage of change in Po, 5.9 Ϯ 6.6%) and dexamethasonetreated (percentage of change in Po, 0.2 Ϯ 14.0%) cells (Fig.  4B) . The inactive okadaic acid analogue norokadone was without effect in dexamethasone-treated cells (percentage of change in Po after cAMP ϩ 100 nM norokadone was Ϫ8.4 Ϯ 6.6%, n ϭ 3). For cAMP ϩ calyculin A, the percentage of change in pretreatment Po in patches from control cells was Ϫ56.9 Ϯ 3.4% (n ϭ 5), and for dexamethasone-treated cells it was Ϫ70.1 Ϯ 11.9% (n ϭ 4). Moreover, application of the catalytic subunit of PP2A (1 unit/ml) to the intracellular face of patches from control cells resulted in a complete blockade of PKA-mediated inhibition of BK channel activity ( Fig. 4B ; percentage of change in pretreatment Po by cAMP in presence of PP2A catalytic subunit was 4.9 Ϯ 4.6%, n ϭ 5).
Because the above data suggest a role for PP2A in mediating the action of dexamethasone, we determined whether pretreatment of cells with dexamethasone enhances PP2A activity per se in AtT20 D16:16 cell extracts. PP2A activity in crude cytosolic or membrane fractions prepared from dexamethasonetreated (1 M, 2 h at 37°C pretreatment) AtT20 D16:16 cells was not significantly different from that in vehicle control treated cells (Fig. 5) , suggesting that a global induction of PP2A-like activity is not responsible for the effects of dexamethasone in this system. DISCUSSION This study demonstrates that (i) BK channels in AtT20 D16:16 corticotropes are dynamically regulated by protein kinase A and protein phosphatase 2A-like activity closely associated with the BK channel complex and (ii) glucocorticoid regulation of BK channels is dependent upon protein phosphatase 2A activity at the level of the BK channel complex. Importantly, this action of glucocorticoids is context-sensitive because glucocorticoids do not modify the intrinsic properties (calcium or voltage sensitivity) of the BK channel; rather they block PKA-mediated inhibition of BK channel activity. These data support our previous electrophysiological and secretion studies in metabolically intact AtT20 D16:16 cells (3), suggest- ing that glucocorticoid-induced proteins render BK channels insensitive to inhibition by PKA and that this action of steroids is central to the mechanism of early inhibition of adrenocorticotropin hormone secretion in this system. Furthermore, these data support a growing body of evidence that suggests that reversible phosphorylation of ion channels acts as a dynamic process to finely tune ion channel behavior (12) (13) (14) (15) 23) .
Mechanism of Glucocorticoid Regulation of BK Channels?-In order to directly examine the effects of PKA activation and protein phosphatases on BK channel behavior in this paper, we examined regulation in isolated patches of membrane from cells that had been pretreated with a maximally effective dose of glucocorticoid so that the full effects of steroidinduced proteins could be exerted on the channel complex. Because PKA-mediated inhibition of BK channel activity was significantly attenuated in isolated patches of membrane, as we previously observed in whole cell current recordings (3), these data strongly suggest that glucocorticoid-induced proteins exert their effect through pathways that are tightly associated with the BK channel complex. Thus it is reasonable to exclude effects of steroid that require the maintained presence of a diffusible mediator. For example, arachidonic acid metabolites and cGMP exert powerful activation of BK channels in pituitary cells through activation of protein phosphatases (14, 15) ; however, glucocorticoids inhibit arachidonic acid release (24) and have no effect on cGMP levels in AtT20 D16:16 cells. 2 Several lines of evidence suggest that the blockade of PKAmediated inhibition of BK channel activity by dexamethasone is a result of modified PP2A-like activity closely associated with the BK channel complex. Firstly, cAMP inhibited BK channel activity in patches from dexamethasone-treated cells when endogenous phosphatase activity was blocked by 10 nM calyculin A or okadaic acid. Secondly, using thiophosphate (ATP␥S) as the phosphate donor, which allows phosphorylation of proteins, although the resultant phosphoprotein is not readily reversible by protein phosphatases, resulted in cAMP-mediated inhibition of BK channels from dexamethasone-treated cells. Thirdly, application of exogenous PP2A catalytic subunit to the intracellular face blocked cAMP-mediated inhibition of BK channels in patches from control cells. Finally, although analysis of protein phosphatase action in intact cells is hampered by the multiple effects on signaling pathways (for example, inhibition of serine threonine phosphatase activity in AtT20 D16:16 cells modifies cAMP accumulation and glucocorticoid receptor function (20, 21) ), inhibition of protein phosphatases with low (10 nM) doses of okadaic acid in intact dexamethasone-pretreated cells inhibits whole cell BK channel currents. 3 Taken together, these data suggest that glucocorticoid-induced proteins exert their effects by modulating the association and/or activation of PP2A in the BK channel complex. Moreover, the effect of glucocorticoids is unlikely to be a result of modulation of PKA activity because cAMP inhibits BK channel activity in patches from dexamethasone-treated cells when ATP␥S is used as the phosphate donor, and previous studies have reported that glucocorticoids do not block cAMP activation of PKA in AtT20 cells (25) .
How may glucocorticoids modulate the association and/or activation of PP2A in the BK channel complex? In other systems, glucocorticoids have been reported to induce serine/threonine as well as tyrosine phosphatase activity (16, 18, 19) through elevation of protein phosphatase levels. However, we observe no significant change in PP2A activity in cytosolic or crude plasma membrane fractions from dexamethasonetreated AtT20 D16:16 cells compared with control precluding a role for a global de novo induction of PP2A. In intact AtT20 D16:16 cells dexamethasone blockade of cAMP-mediated inhibition of BK channel activity is dependent on de novo mRNA and protein synthesis (3) . Thus the recent reports of signaling molecules including serine/threonine phosphatases (26) directly associated with the unliganded glucocorticoid receptor complex and potentially mediating nongenomic actions of glucocorticoids are unlikely to play a significant role in the mechanism of regulation reported here. In addition, because the effect of glucocorticoids is retained in excised patches, it is unlikely that a soluble mediator is involved as discussed above. This suggests that glucocorticoid-induced proteins regulate the function of protein phosphatases specifically associated with the BK channel complex; indeed PKA-mediated inhibition of L-type calcium channels in this system is not blocked by dexamethasone (3), further suggesting specificity of the response. Increasing evidence suggests that ion channels and cognate protein kinases and phosphatases regulating their function are co-localized at the plasma membrane through the interaction of anchoring, targeting, and regulatory intermediary proteins, the interactions of which are themselves dynamically regulated by reversible protein phosphorylation and protein-protein interactions (27) (28) (29) (30) . Thus glucocorticoids, through induced proteins, may exert their effects through modification of the level, or activity, of PP2A in the ion channel complex itself rather than de novo induction of PP2A per se. Identification of the BK channel complex as a target for glucocorticoid action should allow us to define the molecular mechanisms leading from glucocorticoid receptor activation to modulation of protein phosphatase and ion channel activity.
Conclusions and Perspectives-The data in this report demonstrate that glucocorticoid inhibition of BK channel activity is dependent upon protein phosphatase 2A activity closely associated with the BK channel complex. Such a mechanism may be a common determinant to allow the reciprocal regulation of calcium-activated potassium channels by glucocorticoid-induced proteins and cAMP-dependent protein phosphorylation in excitable cells. Identification of the BK channel complex as a target for glucocorticoid action should allow us to characterize glucocorticoid-induced proteins involved in ion channel regulation and provide further insights into the mechanism and role 2 M. J. Shipston, unpublished data.
3 L. Tian and M. J. Shipston, unpublished data.
FIG. 5.
Dexamethasone does not enhance global PP2A activity in AtT20 D16:16 cell extracts. Protein phosphatase activity from cytosolic (S, open bars) and membrane fractions (P, shaded bars) from AtT20 D16:16 cells treated with vehicle alone (Control) or 1 M DEX for 2 h at 37°C and expressed as pmol of phosphate released/g of protein/ min using the synthetic phosphopeptide RRA(pT)VA as substrate at 30°C. Phosphatase activity was determined as the phosphatase activity sensitive to 10 nM okadaic acid, which under the conditions used was Ͼ80% of total phosphatase activity measured. The means Ϯ S.E. are shown (n ϭ 3/group).
of rapid glucocorticoid regulation of excitability in neuroendocrine and neuronal cells.
